JP2009534404A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534404A5
JP2009534404A5 JP2009506740A JP2009506740A JP2009534404A5 JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5 JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5
Authority
JP
Japan
Prior art keywords
alkyl
och
conhch
pyridyl
propenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534404A (ja
JP5480619B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066864 external-priority patent/WO2007124318A1/en
Publication of JP2009534404A publication Critical patent/JP2009534404A/ja
Publication of JP2009534404A5 publication Critical patent/JP2009534404A5/ja
Application granted granted Critical
Publication of JP5480619B2 publication Critical patent/JP5480619B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506740A 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤 Expired - Fee Related JP5480619B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US79369406P 2006-04-20 2006-04-20
US60/793,694 2006-04-20
US87117106P 2006-12-21 2006-12-21
US60/871,171 2006-12-21
PCT/US2007/066864 WO2007124318A1 (en) 2006-04-20 2007-04-18 Inhibitors of c-fms kinase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013228539A Division JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2009534404A JP2009534404A (ja) 2009-09-24
JP2009534404A5 true JP2009534404A5 (enExample) 2010-05-13
JP5480619B2 JP5480619B2 (ja) 2014-04-23

Family

ID=38457966

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009506740A Expired - Fee Related JP5480619B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Country Status (14)

Country Link
US (3) US8674100B2 (enExample)
EP (2) EP2687516A1 (enExample)
JP (2) JP5480619B2 (enExample)
KR (1) KR101462393B1 (enExample)
AR (1) AR060609A1 (enExample)
AU (1) AU2007240439B2 (enExample)
CA (1) CA2649919C (enExample)
ES (1) ES2581600T3 (enExample)
MX (1) MX2008013532A (enExample)
NZ (1) NZ572201A (enExample)
PE (1) PE20080076A1 (enExample)
TW (1) TW200808736A (enExample)
UY (1) UY30298A1 (enExample)
WO (1) WO2007124318A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101891680B (zh) 2004-06-24 2014-10-29 沃泰克斯药物股份有限公司 Atp-结合弹夹转运蛋白的调控剂
US20060281788A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
DK3219705T3 (da) 2005-12-28 2020-04-14 Vertex Pharma Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
EP2016070B1 (en) * 2006-04-20 2016-01-13 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
MX2008013533A (es) 2006-04-20 2009-01-15 Janssen Pharmaceutica Nv Compuestos heterociclicos como inhibidores de c-fms cinasa.
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
MX2008013532A (es) * 2006-04-20 2009-01-15 Janssen Pharmaceutica Nv Inhibidores de c-fms cinasa.
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
KR101727762B1 (ko) 2009-03-20 2017-04-17 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법
CN101624376B (zh) * 2009-08-19 2011-09-14 沈阳中海药业有限公司 取代酰肼类化合物及其应用
NZ597620A (en) * 2009-08-20 2013-08-30 Cipla Ltd A process for the synthesis of naratriptan
EP2627650A2 (en) * 2010-05-26 2013-08-21 Merck Sharp & Dohme Corp. N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
JP2015511583A (ja) 2012-02-27 2015-04-20 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 薬学的組成物およびその投与
CN107266405A (zh) 2012-08-07 2017-10-20 詹森药业有限公司 用于制备c‑fms激酶抑制剂的方法
CN104870454B (zh) 2012-08-07 2020-03-03 詹森药业有限公司 用于制备杂环酯衍生物的方法
HK1206714A1 (en) * 2012-09-17 2016-01-15 霍夫曼-拉罗奇有限公司 Triazole carboxamide derivatives
JP6318467B2 (ja) * 2013-04-18 2018-05-09 Jsr株式会社 液晶配向剤、液晶配向膜、液晶表示素子、位相差フィルム、位相差フィルムの製造方法及び重合体
US10959987B2 (en) 2019-04-15 2021-03-30 King Abdulaziz University Imidazole-based compounds as hepatitis C virus inhibitors
WO2021144360A1 (en) 2020-01-17 2021-07-22 F. Hoffmann-La Roche Ag Small molecule csf-1r inhibitors in therapeutic and cosmetic uses

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69211015T2 (de) * 1991-11-27 1997-01-09 Du Pont Herbizide acylierte amino-(phenyl-oder-pyridinyl-oder thienyl-)phenyl derivate
WO1996011932A1 (en) 1994-10-14 1996-04-25 Smithkline Beecham Plc 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
AU7692896A (en) 1995-12-01 1997-06-27 Novartis Ag Quinazolin-2,4-diazirines as NPY receptor antagonist
US6100254A (en) 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DK1140938T3 (da) * 1999-01-11 2003-12-22 Univ Princeton Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ATE449764T1 (de) 1999-12-28 2009-12-15 Pharmacopeia Inc Cytokine, insbesondere tnf-alpha, hemmer
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
WO2004096795A2 (en) 2003-04-25 2004-11-11 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7790724B2 (en) * 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
US7645755B2 (en) * 2004-10-22 2010-01-12 Janssen Pharmaceutical N.V. Inhibitors of c-fms kinase
US7705042B2 (en) * 2004-10-22 2010-04-27 Janssen Pharmaceutica Nv Class of arylamide compounds useful as inhibitors of c-fms kinase
US7662837B2 (en) * 2004-10-22 2010-02-16 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
BRPI0709817A2 (pt) * 2006-04-12 2011-07-26 Wyeth Corp composto da fàrmula i; mÉtodo para o tratamento de um distérbio do sistema nervoso central relacionado ou afetado pelo receptor de 5-ht6 em um paciente que necessita deste; composiÇço farmacÊutica; e processo para a preparaÇço de um composto da fàrmula i
MX2008013533A (es) * 2006-04-20 2009-01-15 Janssen Pharmaceutica Nv Compuestos heterociclicos como inhibidores de c-fms cinasa.
MX2008013532A (es) * 2006-04-20 2009-01-15 Janssen Pharmaceutica Nv Inhibidores de c-fms cinasa.
EP2016070B1 (en) * 2006-04-20 2016-01-13 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
FR2966596B1 (fr) * 2010-10-26 2012-12-07 Commissariat Energie Atomique Dispositif de detection d'un rayonnement electromagnetique.

Similar Documents

Publication Publication Date Title
JP2009534407A5 (enExample)
JP2008510828A5 (enExample)
JP6466348B2 (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP2002524463A5 (enExample)
JP2011507878A5 (enExample)
JP2012524111A5 (enExample)
JP2012510523A5 (enExample)
JP2013532726A5 (enExample)
JP2011520815A5 (enExample)
JP2009534405A5 (enExample)
JP2007501859A5 (enExample)
JP2007518738A5 (enExample)
JP2008505120A5 (enExample)
JP2009504772A5 (enExample)
JP2012530713A5 (enExample)
JP7811768B2 (ja) ピロール化合物
JP2021527125A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2009545611A5 (enExample)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2010539110A5 (enExample)
JP2006515858A5 (enExample)
JP2005511608A5 (enExample)
JP2013510825A5 (enExample)
JP2018529745A5 (enExample)